News

Breakthrough Therapy Designation was based on results from the Phase I/II RAINFOL-01 trial, which showed encouraging clinical ...
Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA), and Kyle McAllister, co-founder, CEO, Trially, ...
Strategic AI applications are helping life sciences teams overcome hidden bias, accelerate data discovery, and improve ...